Cmbio Launches to Provide a Centralized Hub for Microbiome and Metabolomics Services The new business combines Clinical Microbiomics, CosmosID, MS-Omics, DNASense, and Microba Life Sciences. The combined company has a team of over 100 experts in microbiome and metabolome science and will provide GxP lab services, advanced bioinformatics, and multiomics solutions that support research in human, animal, and planetary health.
